Q3 2024 · 13F-HR
Nan Fung Group Holdings Ltdholdings as filed
Filed 2024-11-13 · accession 0001012975-24-000473
$116.1M
Reported value
38
Positions
2024-09-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 452327109 | ILMN | ILLUMINA INC | $15.5M | 13.4% | 119,196 | Common | SOLE |
| 413197104 | HRMY | HARMONY BIOSCIENCES HLDGS IN | $14.7M | 12.7% | 368,665 | Common | SOLE |
| 374163103 | GERN | GERON CORP | $6.2M | 5.37% | 1,373,550 | Common | SOLE |
| N5749R100 | 2GH | MERUS N V | $6.0M | 5.17% | 120,038 | Common | SOLE |
| 98887Q104 | ZLAB | ZAI LAB LTD | $5.7M | 4.89% | 235,000 | Common | SOLE |
| 54300N103 | — | LONGBOARD PHARMACEUTICALS IN | $5.4M | 4.61% | 160,570 | Common | SOLE |
| H5870P102 | OCS | OCULIS HOLDING AG | $5.3M | 4.61% | 436,378 | Common | SOLE |
| 07725L102 | ONC | BEIGENE LTD | $5.2M | 4.45% | 23,022 | Common | SOLE |
| 45337C102 | INCY | INCYTE CORP | $4.9M | 4.22% | 74,022 | Common | SOLE |
| 98420N105 | XENE | XENON PHARMACEUTICALS INC | $4.2M | 3.62% | 106,680 | Common | SOLE |
| 30223G102 | EXAIEUR | EXSCIENTIA PLC | $4.2M | 3.62% | 859,892 | Common | SOLE |
| 604749101 | MIRM | MIRUM PHARMACEUTICALS INC | $4.1M | 3.56% | 106,100 | Common | SOLE |
| 89157D105 | TRML | TOURMALINE BIO INC | $3.8M | 3.25% | 146,800 | Common | SOLE |
| 34385P108 | LAB | STANDARD BIOTOOLS INC | $3.6M | 3.13% | 1,883,179 | Common | SOLE |
| 834203309 | SLNO | SOLENO THERAPEUTICS INC | $3.2M | 2.78% | 63,950 | Common | SOLE |
| 76029N106 | REPL | REPLIMUNE GROUP INC | $3.2M | 2.72% | 287,846 | Common | SOLE |
| 76243J105 | RYTM | RHYTHM PHARMACEUTICALS INC | $2.6M | 2.22% | 49,120 | Common | SOLE |
| 28658R106 | CLYM | ELIEM THERAPEUTICS INC | $2.4M | 2.03% | 463,654 | Common | SOLE |
| 558868105 | MDGL | MADRIGAL PHARMACEUTICALS INC | $2.1M | 1.78% | 9,762 | Common | SOLE |
| 04351P101 | ASNDUSD | ASCENDIS PHARMA A/S | $2.0M | 1.75% | 13,600 | Common | SOLE |
| 483497103 | KALV | KALVISTA PHARMACEUTICALS INC | $1.8M | 1.54% | 154,522 | Common | SOLE |
| 30161Q104 | EXEL | EXELIXIS INC | $1.7M | 1.44% | 64,200 | Common | SOLE |
| 004225108 | ACAD | ACADIA PHARMACEUTICALS INC | $1.6M | 1.36% | 102,984 | Common | SOLE |
| 753018100 | RANI | RANI THERAPEUTICS HLDGS INC | $1.1M | 0.92% | 493,584 | Common | SOLE |
| 29384C108 | TRDA | ENTRADA THERAPEUTICS INC | $784,330 | 0.68% | 49,082 | Common | SOLE |
| 09061G101 | BMRN | BIOMARIN PHARMACEUTICAL INC | $760,186 | 0.65% | 10,815 | Common | SOLE |
| 097702104 | BOLT1EUR | BOLT BIOTHERAPEUTICS INC | $756,185 | 0.65% | 1,166,952 | Common | SOLE |
| 088786108 | BCYC | BICYCLE THERAPEUTICS PLC | $714,769 | 0.62% | 31,585 | Common | SOLE |
| 09769B107 | — | BOLT PROJS HLDGS INC | $665,801 | 0.57% | 811,952 | Common | SOLE |
| 501575104 | KYMR | KYMERA THERAPEUTICS INC | $514,714 | 0.44% | 10,875 | Common | SOLE |
| 76155X100 | RVMD | REVOLUTION MEDICINES INC | $331,055 | 0.29% | 7,300 | Common | SOLE |
| 85205L107 | SWTXUSD | SPRINGWORKS THERAPEUTICS INC | $238,698 | 0.21% | 7,450 | Common | SOLE |
| 04016X101 | ARGX | ARGENX SE | $233,094 | 0.20% | 430 | Common | SOLE |
| 90400D108 | RARE | ULTRAGENYX PHARMACEUTICAL IN | $212,201 | 0.18% | 3,820 | Common | SOLE |
| 23306J200 | — | DBV TECHNOLOGIES S A | $129,833 | 0.11% | 185,475 | Common | SOLE |
| N01045207 | AFMDQ | AFFIMED N V | $125,150 | 0.11% | 37,247 | Common | SOLE |
| 008064107 | — | AEROVATE THERAPEUTICS INC | $100,186 | 0.09% | 47,936 | Common | SOLE |
| 00166B105 | ALXO | ALX ONCOLOGY HLDGS INC | $76,349 | 0.07% | 41,950 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.